Temptime Corporation

Temptime is deeply committed to improving global public health. Founded in 1987, our scientists developed the first miniaturized technology to monitor temperature exposure of vials containing the oral polio vaccine. This device continues to be the only technology that meets the strict specifications of the world’s leading health organizations, including the World Health Organization, for distributing vaccines to developing countries.

Today, pharmaceutical corporations, biotechnology companies, specialty pharmacies, and hospitals are using our devices to help improve storing and handling thousands of medical products that improve and save lives. Since the medication you use is important and can be affected by extreme temperatures, it is our mission to monitor these products with 100 percent accuracy to ensure they have not been exposed to temperature events that could damage their effectiveness. We are dedicated to continually developing new technologies that will meaningfully improve global health for years to come.